Glucose-dependent arginine stimulation test for characterization of islet function: Studies on reproducibility and priming effect of arginine

Diabetologia

Volumn 41, Issue 7, 1998, Pages 772-777

  Larsson, H ^a   Ahren B ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Arginine; Coefficient of variation; Glucagon secretion; Insulin secretion; Islet function; Priming effect; Reproducibility

Indexed keywords

ARGININE; GLUCOSE; INSULIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DIAGNOSTIC VALUE; FEMALE; GLUCOSE BLOOD LEVEL; HORMONAL REGULATION; HUMAN; INSULIN RELEASE; LABORATORY TEST; PANCREAS FUNCTION; PRIORITY JOURNAL; REPRODUCIBILITY; TECHNIQUE;

ARGININE; BLOOD GLUCOSE; BODY MASS INDEX; FASTING; FEMALE; GLUCAGON; GLUCOSE; GLUCOSE CLAMP TECHNIQUE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN; ISLETS OF LANGERHANS; MIDDLE AGED; REPRODUCIBILITY OF RESULTS;

EID: 0031863755     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250050986     Document Type: Article

References (28)

1. DeFronzo RA, Tobin JD, Andres R (1979) Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237:E214-E223
2. Bardet S, Pasqual C, Maugendre D, Remy JP, Charbonnel B, Sai P (1989) Inter and intra individual variability of acute insulin response during intravenous glucose tolerance tests. Diabetes Metab 15: 224-232
3. Hosker JP, Matthews DR, Rudenski AS et al. (1985) Continuous infusion of glucose with model assessment: measurement of insulin resistance and β-cell function in man. Diabetologia 28: 401-411
4. Scheen AJ, Castillo MJ, Lefebvre PJ (1996) Assessment of residual insulin secretion in diabetic patients using the intravenous glucagon stimulatory test: methodological aspects and clinical applications. Diabetes Metab 22: 397-406
5. Gjessing HJ, Damsgaard EM, Matzen LE, Frøland A, Faber OK (1987) Reproducibility of β-cell function estimates in non-insulin-dependent diabetes mellitus. Diabetes Care 10: 558-562
6. Groop LC, Widén E, Ferrannini E (1993) Insulin resistance and insulin deficiency in the pathogenesis of type II (non-insulin-dependent) diabetes mellitus: errors of metabolism or of methods? Diabetologia 36: 1326-1331
7. Larsson H, Berglund G, Ahrén B (1995) Glucose modulation of insulin and glucagon secretion is altered in impaired glucose tolerance. J Clin Endocrinol Metab 80: 1778-1782
8. Larsson H, Ahrén B (1996) Failure to adequately adapt reduced insulin sensitivity with increased insulin secretion in women with impaired glucose tolerance. Diabetologia 39: 1099-1107
9. Larsson H, Ahrén B (1996) Islet dysfunction in obese women with impaired glucose tolerance. Metabolism 45: 502-509
10. Ward WK, Bolgiano DC, McKnight B, Halter JB, Porte D, Jr (1984) Diminished B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus. J Clin Invest 74: 1318-1328
11. Van Haeften TW, Van Maarschalkerweerd WWA, Gerich JE, Van Der Veen EA (1991) Decreased insulin secretory capacity and normal pancreatic beta-cell glucose sensitivity in non-obese patients with NIDDM. Eur J Clin Invest 21: 168-174
12. Beard JC, Halter JB, Best JD, Pfeifer MA, Porte D, Jr (1984) Dexamethasone-induced insulin resistance enhances B cell responsiveness to glucose level in normal man. Am J Physiol 247:E592-E596
13. Kahn SE, Beard JC, Schwartz MW et al. (1989) Increased β-cell secretory capacity as mechanism for islet adaptation to nicotinic acid-induced insulin resistance. Diabetes 38: 562-568
14. Kahn SE, Klaff LJ, Schwartz MW et al. (1990) Treatment with a somatostatin analog decreases pancreatic B-cell and whole body sensitivity to glucose. J Clin Endocrinol Metab 71: 994-1002
15. Ahrén B, Larsson H, Holst JJ (1997) Effects of glucagon-like peptide-1 on islet function and insulin sensitivity in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 82: 473-478
16. Nesher R, Eylon L, Segal N, Cerasi E (1989) β-cell memory to insulin secretagogues:characterization of the time-dependent inhibitory control system in the isolated rat pancreas. Endocrinology 124: 142-148
17. Cerasi E (1975) Potentiation of insulin release by glucose in man. Acta Endocrinol 79: 511-534
18. Grill V (1981) Time and dose dependencies for priming effect of glucose on insulin. Am J Physiol 240:E24-E31
19. Halter JB, Graf RJ, Porte D, Jr (1979) Potentiation of insulin secretory responses by plasma glucose levels in man: evidence that hyperglycaemia in diabetes compensates for impaired glucose potentiation. J Clin Endocrinol Metab 48: 946-954
20. Porte D, Jr (1991) Banting lecture 1990. β-cells in type II diabetes mellitus. Diabetes 40: 166-180
21. Norusis MJ (1992) SPSS for Windows: Base System User's Guide, Release 5.0. SPSS, Chicago
22. Mooy JM, Grootenhuis PA, de Vries H et al. (1996) Intra-individual variation of glucose, specific insulin and proinsulin concentrations measured by two oral glucose tolerance tests in a general Caucasian population: the Hoorn Study. Diabetologia 39: 298-305
23. Smith CP, Tarn AC, Thomas JM et al. (1988) Between and within subject variation of the first phase insulin response to intravenous glucose. Diabetologia 31: 123-125
24. Abbate SL, Fujimoto WY, Brunzell JD, Kahn SE (1993) Effect of heparin on insulin-glucose interactions measured by the minimal model technique: implications for reproducibility using this model. Metabolism 42: 353-357
25. Steil GM, Murray J, Bergman RN, Buchanan TA (1994) Repeatability of insulin sensitivity and glucose effectiveness from the minimal model. Implications for study design. Diabetes 43: 1365-1371
26. Rayman G, Clark P, Schneider AE, Hales CN (1990) The first phase insulin response to intravenous glucose is highly reproducible. Diabetologia 33: 631-634
27. McNair PD, Colman PG, Alford FP, Harrison LC (1995) Reproducibility of the first-phase insulin response to intravenous glucose is not improved by retrograde cannulation and arterialization or the use of a lower glucose dose. Diabetes Care 18: 1168-1173
28. Efendic S, Lins PE, Cerasi E (1979) Potentiation and inhibition of insulin release in man following priming with glucose and with arginine - effect of somatostatin. Acta Endocrinol 90: 259-271